AIMS: To evaluate, with fundus perimetry, the peripapillary differential light threshold (DLT) in eyes with glaucoma and ocular hypertension (OHT), and compare it with peripapillary retinal nerve fibre layer (RNFL) thickness. METHODS: 35 glaucomatous, 29 OHT and 24 control eyes were included. Peripapillary DLT at 1 degrees from the optic nerve head was quantified with fundus perimetry; peripapillary RNFL thickness was measured over the same area by optical coherence tomography. RESULTS: Mean (SD) peripapillary DLT was 19.2 (1.7), 17.6 (4.2) and 10.1 (6.9) dB in control, OHT and glaucomatous eyes, respectively (p<0.001). Mean (SD) RNFL thickness was 98.4 (35.3), 83.9 (35.1) and 55.8 (28.2) microm, respectively (p<0.001). Mean peripapillary DLT showed higher sensitivity and specificity in differentiating the three groups compared with RNFL thickness. CONCLUSION: Progressive, significant reduction of peripapillary DLT was documented in OHT and glaucomatous eyes compared with controls (p<0.001). DLT reduction parallels RNFL reduction.
AIMS: To evaluate, with fundus perimetry, the peripapillary differential light threshold (DLT) in eyes with glaucoma and ocular hypertension (OHT), and compare it with peripapillary retinal nerve fibre layer (RNFL) thickness. METHODS: 35 glaucomatous, 29 OHT and 24 control eyes were included. Peripapillary DLT at 1 degrees from the optic nerve head was quantified with fundus perimetry; peripapillary RNFL thickness was measured over the same area by optical coherence tomography. RESULTS: Mean (SD) peripapillary DLT was 19.2 (1.7), 17.6 (4.2) and 10.1 (6.9) dB in control, OHT and glaucomatous eyes, respectively (p<0.001). Mean (SD) RNFL thickness was 98.4 (35.3), 83.9 (35.1) and 55.8 (28.2) microm, respectively (p<0.001). Mean peripapillary DLT showed higher sensitivity and specificity in differentiating the three groups compared with RNFL thickness. CONCLUSION: Progressive, significant reduction of peripapillary DLT was documented in OHT and glaucomatous eyes compared with controls (p<0.001). DLT reduction parallels RNFL reduction.
Authors: Mohamed A E Soliman; Thomas J T P Van Den Berg; Al-Araby A Ismaeil; Leo A M S De Jong; Marc D De Smet Journal: Am J Ophthalmol Date: 2002-02 Impact factor: 5.258
Authors: Catherine Boden; John Pascual; Felipe A Medeiros; Makoto Aihara; Robert N Weinreb; Pamela A Sample Journal: Invest Ophthalmol Vis Sci Date: 2005-07 Impact factor: 4.799
Authors: Viviane Guedes; Joel S Schuman; Ellen Hertzmark; Gadi Wollstein; Anthony Correnti; Ronald Mancini; David Lederer; Serineh Voskanian; Leonardo Velazquez; Helena M Pakter; Tamar Pedut-Kloizman; James G Fujimoto; Cynthia Mattox Journal: Ophthalmology Date: 2003-01 Impact factor: 12.079
Authors: D C Hood; N Harizman; F N Kanadani; T M Grippo; S Baharestani; V C Greenstein; J M Liebmann; R Ritch Journal: Br J Ophthalmol Date: 2007-02-14 Impact factor: 4.638
Authors: Quraish Ghadiali; Donald C Hood; Clara Lee; Jack Manns; Alex Llinas; Larissa K Grover; Vivienne C Greenstein; Jeffrey M Liebmann; Jeffrey G Odel; Robert Ritch Journal: J Glaucoma Date: 2008-08 Impact factor: 2.503